🔗 Share this article Chancellor Reeves Intends Specific Measures on Household Expenses in Upcoming Financial Plan Chancellor Reeves has announced she is planning "specific steps to tackle household expense challenges" in the forthcoming financial statement. Speaking to the BBC, she stated that reducing price rises is a joint responsibility of both the government and the Bank of England. The UK's price growth is projected to be the highest among the G7 industrialized countries this year and the following year. Potential Energy Bill Interventions Sources suggest the government could intervene to bring down energy bills, such as by cutting the present 5% level of value-added tax charged on energy. A further option is to lower some of the government charges currently added to household expenses. Fiscal Limitations and Analyst Predictions The administration will receive the next report from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will reveal how much room there is for these measures. The expectation from the majority of experts is that Reeves will have to introduce tax rises or expenditure reductions in order to adhere to her self-imposed fiscal targets. Earlier on Thursday, estimates showed there was a twenty-two billion pound gap for the Treasury chief to resolve, which is at the lower end of projections. "There's a joint responsibility between the central bank and the administration to continue tackling some of the drivers of price increases," Reeves told reporters in Washington, at the conferences of the IMF and World Bank. Revenue Commitments and Global Issues While a great deal of the focus has been on probable tax rises, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to manifesto promises not to raise rates on earnings tax, sales tax or social security contributions. She attributed an "unpredictable world" with increasing geopolitical and commercial tensions for the Budget revenue measures, probably to be focused on those "wealthiest." International Economic Tensions Referring to apprehensions about the UK's economic relations with China she said: "The UK's security interests invariably take priority." Last week's statement by Chinese authorities to tighten export controls on critical minerals and other resources that are key for high-technology manufacturing led US President Donald Trump to propose an extra 100% import tax on imports from the Asian country, increasing the risk of an full-scale commercial conflict between the two largest economies. The American finance chief described China's decision "commercial pressure" and "a global supply chain power grab." Asked about accepting the American proposal to join its battle with the Asian nation, the Chancellor said she was "deeply worried" by China's actions and urged the Chinese government "to avoid restrictions and limit trade." She said the action was "damaging for the global economy and causes further headwinds." "I believe there are sectors where we need to address Chinese policies, but there are also significant chances to export to Chinese markets, including banking sector and other sectors of the economy. We've got to get that balance right." The Treasury chief also stated she was working with international partners "regarding our own essential resources strategy, so that we are reduced dependence." NHS Drug Pricing and Funding The Chancellor also acknowledged that the cost the National Health Service pays for medicines could rise as a consequence of ongoing talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and funding. A number of the world's largest drug companies have said lately that they are either pausing or abandoning projects in the UK, with some blaming the modest returns they are receiving. Last month, the Science Minister said the price the health service spends on drugs would need to go up to halt companies and pharmaceutical investment leaving the UK. The Chancellor told media: "It has been observed due to the cost structure, that medical research, new drugs have not been offered in the United Kingdom in the way that they are in other continental states." "We want to ensure that patients receiving treatment from the NHS are able to access the top essential medicines in the world. And so we are reviewing this situation, and... aiming to obtain more capital into Britain."